Observational studyJournal of the American Heart Association2025

Characteristics and Outcomes of Mavacamten Use in 2440 Patients With Obstructive Hypertrophic Cardiomyopathy.

Ingy Mahana et al.PubMed ↗Full text ↗Publisher ↗

No numbers read from the abstract.